SPEAKERS

Alexandre Diaz

Head of Business Development

ALPX

Alexandros Patsilinakos

Head of Medicinal Chemistry

Sibylla Biotech

Andrea Testa

Senior Director of Chemistry

Trimtech Therapeutics

Andrea Unzue Lopez

Andrea Unzue Lopez

Head TPD Chemistry

Merck Group

Andreas MANTOULIDIS

Research Lab Head

Boehringer Ingelheim

Andrew Potterton

Chief Technology Officer

Ternary Therapeutics

Andy Pike

Project leader, DMPK, Oncology R&D

AstraZeneca

Arnout Schepers

Chief Executive Officer

TenAces Biosciences

Chinatsu Sakata-Sakurai

Vice-President, Primary Focus Lead, Targeted Protein Degradation

Astellas Pharma

Chris Tame

Chief Executive Officer

Ternary Therapeutics

Elizabeth Caine

scientist

Promega Corporation

Eloise Jarvis

Researcher

Beacon

Gali Prag

Co-Founder

Coltac Therapeutics

Giovanni Spagnolli

Chief Technology Officer

Sibylla Biotech

Hailong Zhang

Chief Executive Officer

Innoxtal

Heide Duevel

PROTAC Technology Platform Lead

Merck Healthcare KGaA

Henrik Daub

Chief Scientific Officer

NEOsphere Biotechnologies

Iacovos Michaelides

Iacovos Michaelides

Associate Principal Scientist

AstraZeneca

Jia Lu

Principal Scientist

PhoreMost

Kevin Wilson

Vice President & Head of Chemistry

Foghorn Therapeutics

Koichi Ito

Senior Director, Biology

Prelude Therapeutics

Kurt Pike

Senior Director

Johnson & Johnson Innovation

Luc Brunsveld

Professor of Chemical Biology, Eindhoven University of Technology & Co-Founder

Ambagon Therapeutics Inc

Markus Queisser

Scientific Director

GlaxoSmithKline

Marta Carrara

Associate Director

Amphista Therapeutics

Maureen Galmes-Spit

Vice President of Research

Laigo Bio

Maureen Galmes-Spit

Vice President of Research

Laigo Bio

Randolph Lopez

Co-founder & Chief Technology Officer

A-Alpha Bio

Rick Ewing

Vice President & Head of Chemistry

Rapafusyn Pharmaceuticals

Simon Glerup

Chief Scientific Officer

Draupnir Bio

Vivek Vishnudas

Chief Technology Officer

BPG Bio

William Mcewan

Sir Henry Dale Fellow

UK Dementia Research Institute, University of Cambridge

Zhangping Xiao

Marie Curie Fellow Postdoc, Tate Group

Imperial College London

Zoran Rankovic

Director, Center for Protein Degradation

Institute of Cancer Research